Given that no therapeutic methods of postoperative adjuvant chemotherapy for non-small-cell lung cancer have been established, we selected UFT (tegafur and uracil) for investigation because UFT is less injurious to the host
Fumihiro Tanaka, MD
Advertisement
Articles by Fumihiro Tanaka, MD
Advertisement
Latest Updated Articles
- Postoperative Adjuvant Chemotherapy for Non-Small-Cell Lung Cancer
September 2nd 1997
Advertisement
Advertisement
Trending on CancerNetwork
1
In Vivo CAR Engineering and the Next Phase of Cellular Immunotherapy
2
Synchronous Endometrial and Ovarian Cancers: A Case Study and Literature Review
3
FDA Delays Decision on Subcutaneous Isatuximab in Multiple Myeloma
4
3 Things You Should Know About TROP2-Directed Antibody-Drug Conjugates in the Frontline Treatment of Metastatic Triple-Negative Breast Cancer
5